What is HearBright?
Headquartered in San Jose, California, HearBright operates as a specialized provider of advanced hearing care services and high-fidelity hearing aid technology. The firm distinguishes itself through a holistic, patient-centric methodology that integrates clinical audiological evaluations with personalized treatment plans. Their portfolio includes premium devices from industry-leading manufacturers such as Oticon, Phonak, and Starkey, complemented by specialized clinical interventions including tinnitus management and professional earwax removal. By prioritizing a whole-person approach, HearBright has established itself as a trusted authority in the regional medical community, bridging the gap between complex audiological science and everyday patient accessibility.
How much funding has HearBright raised?
HearBright has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in HearBright
PPP
Public-Private Partnership
What's next for HearBright?
With the successful closure of this late-stage financing round, HearBright is poised to accelerate its operational expansion and technological integration. The strategic deployment of this capital will likely focus on enhancing clinical infrastructure, potentially expanding the reach of its specialized tinnitus treatment programs, and optimizing the patient experience through digital health advancements. As the company navigates this growth phase, the focus remains on maintaining the high standard of care that has defined its reputation, while simultaneously exploring opportunities to scale its service model to meet the rising demand for comprehensive hearing health solutions in an aging population.
See full HearBright company page
